
Takara Bio USA wins EU opposition hearing – Jumpcode Genomics’ RNA-seq library enrichment patent revoked
Takara Bio USA today announced that it has once again prevailed in its second patent…
Takara Bio USA today announced that it has once again prevailed in its second patent…
Relationship leverages Quest’s sequencing and specimen collection expertise with Scipher’s precision medicine technology Quest Diagnostics…
Lexogen, a pioneer in the field of genomics and transcriptomics, is proud to introduce the…
Fluent BioSciences, a cutting-edge life science company transforming single cell analysis through simple, cost-effective, and…
Stellaromics, a leading provider of in situ spatial multi-omics technology, today announced that the company…
SYNLAB’s myEDIT-B is the world’s first blood-based test for the differential diagnosis between bipolar disorder…
Almaden Genomics has added pre-built workflows for single-cell RNA-seq analysis to its g.nome platform, enabling…
Single-cell analysis can help tease apart heterogeneity in complex cell populations, distinguishing cell types and…
NVIGEN, a leading provider of modern nanoparticle solutions to empower revolutionary personalized healthcare, announces its…
The global RNA sequencing market is witnessing rapid growth, driven by the increasing adoption of…